How much funding has Kiwi Biosciences raised?

Kiwi Biosciences has raised $1.5M in total funding, most recently a Seed round.

When was Kiwi Biosciences founded?

Kiwi Biosciences was founded in 2020.

Where is Kiwi Biosciences headquartered?

Kiwi Biosciences is headquartered in Boston, Massachusetts, United States.

What industry is Kiwi Biosciences in?

Kiwi Biosciences operates in Biotech, Food Tech, Healthcare.

How many employees does Kiwi Biosciences have?

Kiwi Biosciences has 1-10 employees.

Kiwi Biosciences

Q: Who are Kiwi Biosciences's investors?

Kiwi Biosciences's investors include Y Combinator Continuity Fund, North South Ventures.

Patent-pending enzymes to break down common dietary triggers

Boston, United States · Founded 2020 · $1.5M raised

Biotech

Food Tech

Healthcare

YC S21

Headquarters: Boston, Massachusetts
Employees: 1–10
Founded: 2020
Website: fodzyme.com

Total Funding: $1.5M
Last Round: $1.5M SeedOct 2021
Rounds: 1

About

Kiwi Biosciences can help 18M Americans suffering from Irritable Bowel Syndrome (IBS) enjoy a normal meal without running to the bathroom two hours later. We develop novel, patent-pending enzymes that break down common digestive triggers in food.

Summary

Kiwi Biosciences is a Biotech company based in Boston, United States, founded in 2020. It has raised $1.5M in total across 1 round, most recently a $1.5M Seed round in Oct 2021. Investors include Y Combinator Continuity Fund and North South Ventures.